State-Owned Champions
Discover a carefully selected portfolio of former government-run enterprises that now trade publicly. These companies combine the market dominance of traditional state monopolies with the growth potential unlocked by private capital, offering a unique balance of stability and opportunity.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Companhia de Saneamento Basico
SBS
Current price
$20.96
As the primary water and sanitation utility for the state of Sao Paulo, it represents a classic state-controlled service now accessible to public inve...
As the primary water and sanitation utility for the state of Sao Paulo, it represents a classic state-controlled service now accessible to public investors.
Korea Electric Power Corp.
KEP
Current price
$13.38
This company is South Korea's principal electric utility, making it a strategic national asset that has been partially privatized and is traded on the...
This company is South Korea's principal electric utility, making it a strategic national asset that has been partially privatized and is traded on the stock market.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
This collection targets companies with deep governmental roots that now operate as public corporations in essential sectors. The investment thesis capitalizes on their established market dominance while benefiting from the improved efficiency and growth discipline introduced through privatization and public market accountability.
What You Need to Know
These former state monopolies typically command significant market share in foundational industries like utilities, telecommunications, and transportation infrastructure. They often provide essential services to millions, operate in regulated environments, and frequently offer dividend income potential from their steady revenue streams.
Why These Stocks
We've identified companies that maintained their strategic importance while successfully transitioning to a public-private structure. Many benefit from infrastructure modernization initiatives and energy transition mandates, creating opportunities for sustained capital investment and growth despite their established market positions.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+9.60%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 9.6% over the next year.
Stocks Rated Buy by Analysts
12 of 14 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 2.5% return last month.
Why You'll Want to Watch These Stocks
Stability With Growth Potential
These former state monopolies offer rare defensive positioning while still capturing upside from infrastructure modernization and energy transition initiatives.
Dividend Income Champions
Many of these companies distribute steady dividends backed by essential services revenue, potentially creating a reliable income stream other investments might miss.
Global Infrastructure Play
Gain exposure to critical infrastructure assets across multiple countries as governments worldwide funnel capital toward upgrading aging systems and greening their economies.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.